A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: A quality improvement report

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Walker, Rachael C ^a,b   Marshall, Mark R ^c,d   Polaschek, Nick R ^e  

^a Hawke's Bay District Health Board   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Division of Medicine Emergency and Integrated Care   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e MINISTRY OF HEALTH   (New Zealand)

Author keywords

Chronic kidney disease; Nurse practitioner; Prevention; Primary care; Quality improvement

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ALBUMINURIA; BLOOD; BLOOD PRESSURE; BODY MASS; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEPHROLOGY NURSING; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING; NURSING PRACTICE; PATIENT EDUCATION; PRIMARY HEALTH CARE; PROCEDURES; PROSPECTIVE STUDY; PROTEINURIA; RISK REDUCTION; SECONDARY PREVENTION; SELF CARE; SMOKING; THERAPY; TOTAL QUALITY MANAGEMENT;

ALBUMINURIA; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NEPHROLOGY NURSING; NEW ZEALAND; PATIENT EDUCATION AS TOPIC; PRACTICE PATTERNS, NURSES'; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PROTEINURIA; QUALITY IMPROVEMENT; RENAL INSUFFICIENCY, CHRONIC; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; SELF CARE; SMOKING;

EID: 84907980511     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-15-155     Document Type: Article

References (42)

1. The organization and financing of dialysis and kidney transplantation services in New Zealand. Ashton T, Marshall MR, Int J Health Care Finance Econ 2007 7 4 233 252 10.1007/s10754-007-9023-x 17638073
2. Estimating the financial cost of chronic kidney disease to the NHS in England. Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B, Nephrol Dial Transplant 2012 27 Suppl 3 ii73 iii80 22815543
3. Summary of KDIGO guideline: what do we really know about management of blood pressure in patients with chronic kidney disease? Wheeler DC, Becker GJ, Kidney Int 2013 83 3 377 383 10.1038/ki.2012.425 23325075
4. Diabetes, cardiovascular risk and nephropathy. Hahr AJ, Molitch ME, Cardiol Clin 2010 28 3 467 475 10.1016/j.ccl.2010.04.006 20621251
5. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, JAMA 2001 286 4 421 426 10.1001/jama.286.4.421 11466120
6. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-y, N Engl J Med 2004 351 13 1296 1305 10.1056/NEJMoa041031 15385656
7. Stock and flow. Grace B, Hurst K, McDonald SP, ANZDATA Registry Report 2010 Adelaide, South Australia: ANZDATA Registry, Hurst K, McDonald SP, 2012
8. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C, Health Technol Assess 2010 14 21 1 184
9. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ, Am J Kidney Dis 2009 53 3 Suppl 3 71 S77 19231764
10. Guidelines: early identification and management of chronic kidney disease: summary of NICE guidance. Crowe E, Halpin D, Stevens P, BMJ 2008 337 7673 812 815
11. Ethnic differences in Type 2 diabetes care and outcomes in Auckland: a multiethnic community in New Zealand. Robinson T, Simmons D, Scott D, Howard E, Pickering K, Cutfield R, Baker J, Patel A, Wellingham J, Morton S, N Z Med J 2006 119 1235 1997 16751821
12. Health status of New Zealand European, Maori, and Pacific patients with diabetes at 242 New Zealand general practices. Tomlin A, Tilyard M, Dawson A, Dovey S, N Z Med J 2006 119 1235 2004 16751827
13. Nurse practitioner care improves renal outcome in patients with CKD. Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF, J Am Soc Nephrol 2014 25 2 390 398 10.1681/ASN.2012121222 24158983
14. The impact of self-management support on the progression of chronic kidney disease-a prospective randomized controlled trial. Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS, Nephrol Dial Transplant 2011 26 11 3560 3566 10.1093/ndt/gfr047 21414969
15. Self-Management Programmes in Stages 1-4 Chronic Kidney Disease: A Literature Review. Bonner A, Havas K, Douglas C, Thepha T, Bennett P, Clark R, J Ren Care 2014 40 3 194 204 10.1111/jorc.12058 24628848
16. The genesis of advanced nursing practice in New Zealand: policy, politics and education. Jacobs SH, Boddy JM, Nurs Prax N Z 2008 24 1 11 22 18557367
17. Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Davidoff F, Batalden P, Stevens D, Ogrinc G, Mooney S, Qual Saf Health Care 2008 17 Suppl 1 3 i9 10.1136/qshc.2008.029066 18836063
18. The CARI guidelines: Urine protein as diagnostic test: testing for proteinuria. Caring for Australians with Renal I, Nephrol 2004 9 Suppl 3 3 S7
19. The CARI guidelines: Prevention and management of chronic kidney disease in type 2 diabetes. Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, Campbell D, Nicholls K, Tong A, Mangos G, Stack A, MacIsaac RJ, Girgis S, Colagiuri R, Colagiuri S, Craig J, Nephrol 2010 15 Suppl 1 162 S194
20. The CARI guidelines: Prevention of progression of kidney disease. Harris D, Thomas M, Johnson D, Nicholls K, Gillin A, Caring for Australasians with Renal I, Nephrol 2006 11 Suppl 1 2 S197
21. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, JAMA 2003 289 19 2560 2572 10.1001/jama.289.19.2560 12748199
22. Chronic disease self-management: implementation with and within Australian general practice. Harris MF, Williams AM, Dennis SM, Zwar NA, Davies GP, Med J Aust 2008 189 10 17 18601635
23. New Zealand Guidelines Group, New Zealand Cardiovascular Guidelines Handbook: A summary resource for primary care practitioners Wellington: (New Zealand): Ministry of Health 2 2009
24. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H, Ann Fam Med 2012 10 2 142 151 10.1370/afm.1337 22412006
25. Prevalence and patterns of multimorbidity in Australia. Britt HC, Harrison CM, Miller GC, Knox SA, Med J Aust 2008 189 2 72 77 18637770
26. Abbreviated guidelines for scoring the Cumulative Illness Rating Scale (CIRS) in family practice. Hudon C, Fortin M, Soubhi H, J Clin Epidemiol 2007 60 2 212 17208130
27. Development of New Zealand's deprivation index (NZDep) and its uptake as a national policy tool. Salmond CE, Crampton P, Can J Public Health 2012 103 8 Suppl 2 7 S11 23618071
28. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, Kusek JW, Van Lente F, Ann Intern Med 2006 145 4 247 254 10.7326/0003-4819-145-4-200608150-00004 16908915
29. The Partners in Health scale: The development and psychometric properties of a generic assessment scale for chronic condition self-management. Battersby MW, Ask A, Reece MM, Markwick MJ, Collins JP, Aust J Prim Health 2003 9 3 41 52 10.1071/PY03022
30. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Stevens PE, O'Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, Hague N, New J, Farmer CK, Kidney Int 2007 72 1 92 99 10.1038/sj.ki.5002273 17440495
31. Management of chronic kidney disease in an academic primary care clinic. Israni A, Korzelius C, Townsend R, Mesler D, Am J Nephrol 2003 23 1 47 54 10.1159/000066296 12373080
32. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Richards N, Harris K, Whitfield M, O'Donoghue D, Lewis R, Mansell M, Thomas S, Townend J, Eames M, Marcelli D, Nephrol Dial Transplant 2008 23 2 549 555 18065826
33. A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial. Hotu C, Bagg W, Collins J, Harwood L, Whalley G, Doughty R, Gamble G, Braatvedt G, Investigators D, Nephrol Dial Transplant 2010 25 10 3260 3266 10.1093/ndt/gfq168 20375028
34. The impact of nutrition intervention on quality of life in pre-dialysis chronic kidney disease patients. Campbell KL, Ash S, Bauer JD, Clin Nutr 2008 27 4 537 544 10.1016/j.clnu.2008.05.002 18584924
35. Education for patients with chronic kidney disease in Taiwan: a prospective repeated measures study. Yen M, Huang JJ, Teng HL, J Clin Nurs 2008 17 21 2927 2934 10.1111/j.1365-2702.2008.02348.x 19012761
36. U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2013
37. Diabetic kidney disease: act now or pay later. Atkins RC, Zimmet P, Nephrol Dial Transplant 2010 25 2 331 333 10.1093/ndt/gfp757 20093271
38. Mortality rates in trials of subjects with type 2 diabetes. Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA, J Am Heart Assoc 2012 1 1 8 15 10.1161/JAHA.111.000059 23130114
39. Effects of individual self-management education on clinical, biological, and adherence outcomes in asthma. Janson SL, Fahy JV, Covington JK, Paul SM, Gold WM, Boushey HA, Am J Med 2003 115 8 620 626 10.1016/j.amjmed.2003.07.008 14656614
40. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B, Diabetes Care 2004 27 9 2154 2160 10.2337/diacare.27.9.2154 15333477
41. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM, Am J Kidney Dis 2010 56 3 447 457 10.1053/j.ajkd.2010.02.348 20471734
42. Tools and Strategies for Quality Improvement and Patient Safety Rockville, US: Agency for Healthcare Research and Quality, Hughes RG, 2008